Your browser doesn't support javascript.
loading
Risk of secondary progressive multiple sclerosis: A longitudinal study.
Fambiatos, Adam; Jokubaitis, Vilija; Horakova, Dana; Kubala Havrdova, Eva; Trojano, Maria; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Lugaresi, Alessandra; Izquierdo, Guillermo; Grand'Maison, Francois; Grammond, Pierre; Sola, Patrizia; Ferraro, Diana; Alroughani, Raed; Terzi, Murat; Hupperts, Raymond; Boz, Cavit; Lechner-Scott, Jeannette; Pucci, Eugenio; Bergamaschi, Roberto; Van Pesch, Vincent; Ozakbas, Serkan; Granella, Franco; Turkoglu, Recai; Iuliano, Gerardo; Spitaleri, Daniele; McCombe, Pamela; Solaro, Claudio; Slee, Mark; Ampapa, Radek; Soysal, Aysun; Petersen, Thor; Sanchez-Menoyo, Jose Luis; Verheul, Freek; Prevost, Julie; Sidhom, Youssef; Van Wijmeersch, Bart; Vucic, Steve; Cristiano, Edgardo; Saladino, Maria Laura; Deri, Norma; Barnett, Michael; Olascoaga, Javier; Moore, Fraser; Skibina, Olga; Gray, Orla; Fragoso, Yara; Yamout, Bassem; Shaw, Cameron.
Afiliación
  • Fambiatos A; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
  • Jokubaitis V; Central Clinical School, Monash University, Melbourne, VIC, Australia The Alfred, Melbourne, VIC, Australia.
  • Horakova D; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University in Prague, Prague, Czech Republic.
  • Kubala Havrdova E; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University in Prague, Prague, Czech Republic.
  • Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.
  • Prat A; Hopital Notre-Dame, Montreal, QC, Canada/CHUM and Universite de Montreal, Montreal, QC, Canada.
  • Girard M; Hopital Notre-Dame, Montreal, QC, Canada/CHUM and Universite de Montreal, Montreal, QC, Canada.
  • Duquette P; Hopital Notre-Dame, Montreal, QC, Canada/CHUM and Universite de Montreal, Montreal, QC, Canada.
  • Lugaresi A; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Riabilitazione Sclerosi Multipla, Bologna, Italy/Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
  • Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Grand'Maison F; Neuro-Rive-Sud, Greenfield Park, QC, Canada.
  • Grammond P; CISSS de Chaudière-Appalache, Centre-Hospitalier, Levis, Canada.
  • Sola P; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
  • Ferraro D; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
  • Alroughani R; Amiri Hospital, Kuwait City, Kuwait.
  • Terzi M; Medical Faculty, Ondokuz Mayis University, Samsun, Turkey.
  • Hupperts R; Zuyderland Ziekenhuis, Sittard, The Netherlands.
  • Boz C; TU Medical Faculty, Farabi Hospital, Karadeniz Technical University, Trabzon, Turkey.
  • Lechner-Scott J; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia/Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, NSW, Australia.
  • Pucci E; UOC Neurologia, Azienda Sanitaria Unica Regionale Marche, Macerata, Italy.
  • Bergamaschi R; IRCCS Mondino Foundation, Pavia, Italy.
  • Van Pesch V; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Ozakbas S; Dokuz Eylul University, Izmir, Turkey.
  • Granella F; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Turkoglu R; Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
  • Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
  • Spitaleri D; Azienda Ospedaliera di Rilievo Nazionale, San Giuseppe Moscati - Avellino, Avellino, Italy.
  • McCombe P; The University of Queensland, Brisbane, QLD, Australia/Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
  • Solaro C; Ospedale P.A. Micone, Genova, Italy.
  • Slee M; Flinders University, Adelaide, SA, Australia.
  • Ampapa R; Nemocnice Jihlava, Jihlava, Czech Republic.
  • Soysal A; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.
  • Petersen T; Kommunehospitalet, Arhus, Denmark.
  • Sanchez-Menoyo JL; Hospital de Galdakao-Usansolo, Galdakao, Spain.
  • Verheul F; Groene Hart Ziekenhuis, Gouda, The Netherlands.
  • Prevost J; CSSS Saint-Jérôme, Saint-Jerome, QC, Canada.
  • Sidhom Y; Department of Neurology, Razi Hospital, Manouba, Tunisia.
  • Van Wijmeersch B; Rehabilitation and MS-Centre Overpelt and Hasselt University, Hasselt, Belgium.
  • Vucic S; Westmead Hospital, Sydney, NSW, Australia.
  • Cristiano E; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Saladino ML; Institute of Neurosciences Buenos Aires, Buenos Aires, Argentina.
  • Deri N; Hospital Fernandez, Buenos Aires, Argentina.
  • Barnett M; Brain and Mind Centre, Sydney, NSW, Australia.
  • Olascoaga J; Hospital Universitario Donostia-Instituto de Investigación Sanitaria Biodonostia, San Sebastian, Spain.
  • Moore F; Jewish General Hospital, Montreal, QC, Canada.
  • Skibina O; The Alfred, Melbourne, VIC, Australia.
  • Gray O; South East Trust, Belfast, UK.
  • Fragoso Y; Universidade Metropolitana de Santos, Santos, Brazil.
  • Yamout B; American University of Beirut Medical Center, Beirut, Lebanon.
  • Shaw C; Geelong Hospital, Geelong, VIC, Australia.
Mult Scler ; 26(1): 79-90, 2020 01.
Article en En | MEDLINE | ID: mdl-31397221
BACKGROUND: The risk factors for conversion from relapsing-remitting to secondary progressive multiple sclerosis remain highly contested. OBJECTIVE: The aim of this study was to determine the demographic, clinical and paraclinical features that influence the risk of conversion to secondary progressive multiple sclerosis. METHODS: Patients with adult-onset relapsing-remitting multiple sclerosis and at least four recorded disability scores were selected from MSBase, a global observational cohort. The risk of conversion to objectively defined secondary progressive multiple sclerosis was evaluated at multiple time points per patient using multivariable marginal Cox regression models. Sensitivity analyses were performed. RESULTS: A total of 15,717 patients were included in the primary analysis. Older age (hazard ratio (HR) = 1.02, p < 0.001), longer disease duration (HR = 1.01, p = 0.038), a higher Expanded Disability Status Scale score (HR = 1.30, p < 0.001), more rapid disability trajectory (HR = 2.82, p < 0.001) and greater number of relapses in the previous year (HR = 1.07, p = 0.010) were independently associated with an increased risk of secondary progressive multiple sclerosis. Improving disability (HR = 0.62, p = 0.039) and disease-modifying therapy exposure (HR = 0.71, p = 0.007) were associated with a lower risk. Recent cerebral magnetic resonance imaging activity, evidence of spinal cord lesions and oligoclonal bands in the cerebrospinal fluid were not associated with the risk of conversion. CONCLUSION: Risk of secondary progressive multiple sclerosis increases with age, duration of illness and worsening disability and decreases with improving disability. Therapy may delay the onset of secondary progression.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Índice de Severidad de la Enfermedad / Progresión de la Enfermedad / Esclerosis Múltiple Crónica Progresiva / Esclerosis Múltiple Recurrente-Remitente / Factores Inmunológicos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Índice de Severidad de la Enfermedad / Progresión de la Enfermedad / Esclerosis Múltiple Crónica Progresiva / Esclerosis Múltiple Recurrente-Remitente / Factores Inmunológicos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Australia